Results 31 to 40 of about 48,365 (251)

POST-OPERATIVE HYPOCALCEMIA AMONG ONGOING PATIENTS AFTER TOTAL AND SUBTOTAL THYROIDECTOMY

open access: yesThe Iraqi Journal of Medical Sciences, 2018
Background: Hypocalcemia is a major post-operative complication of total thyroidectomy, causing severe symptoms and increasing hospitalization time. The primary cause is secondary hypoparathyroidism following damage to or devascularization of one or more
Raghad Naji
doaj   +1 more source

Familial hypomagnesaemia, Hypercalciuria and Nephrocalcinosis associated with a novel mutation of the highly conserved leucine residue 116 of Claudin 16 in a Chinese patient with a delayed diagnosis: A case report [PDF]

open access: yes, 2018
Background: Sixty mutations of claudin 16 coding gene have been reported in familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) patients. Recent investigations revealed that a highly conserved glycine-leucine-tryptophan (115G-L-W117)
Bottillo, I   +5 more
core   +1 more source

The Effect of Hypomagnesemia on Refractory Hypocalcemia after Total Thyroidectomy: A Single-Center Prospective Cohort Study

open access: yesIndian Journal of Endocrinology and Metabolism, 2020
Background: Hypomagnesemia is known to impede hypocalcemia correction. This prospective observational study aimed to evaluate the impact of serum magnesium levels on the development of refractory hypocalcemia, which remains a concerning problem after ...
Poongkodi Karunakaran   +4 more
doaj   +1 more source

Risk factors and outcomes of incidental parathyroidectomy in thyroidectomy: A systematic review and meta-analysis. [PDF]

open access: yesPLoS ONE, 2018
INTRODUCTION:Postoperative hypocalcemia is the most common complication of thyroidectomy. Incidental parathyroidectomy (IP) was thought to be associated with postoperative hypocalcemia.
Binglong Bai, Zhiye Chen, Wuzhen Chen
doaj   +1 more source

Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia. [PDF]

open access: yes, 2014
Ofatumumab is a humanized anti-CD20 monoclonal antibody that has been approved by the FDA for the treatment of patients with chronic lymphocytic leukemia. We conducted a phase II single-arm study at a single center.
Almahasnah, E   +6 more
core   +3 more sources

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi   +5 more
wiley   +1 more source

hypocalcemia

open access: yes
Abstract This chapter guides the reader on the diagnosis and management of hypocalcemia in hospitalized patients.
Ateeqa Mubarak   +2 more
  +5 more sources

Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia [PDF]

open access: yes, 2020
To evaluate safety and efficacy of one- vs. two-session radiofrequency ablation (RFA) of parathyroid hyperplasia for patients with secondary hyperparathyroidism (SHPT) and to compare the outcome of both methods on hypocalcemia.
He, Hong-Feng   +7 more
core   +1 more source

Strategies for Loading and Releasing Peptide Therapeutics in Biodegradable Carriers

open access: yesAdvanced Functional Materials, EarlyView.
A biodegradable carrier‐based peptide delivery system is a powerful treatment platform for diverse diseases, owing to its superior therapeutic efficacy and low toxicity. This review examines the conventional peptide‐loaded carrier fabrication process and its current limitations.
Wookyoung Jang, Ki Wan Bong
wiley   +1 more source

Case Reports : Two patients with parathyroid hormone suppression caused by proton pump inhibitors [PDF]

open access: yes, 2017
Hypocalcemia can be associated with coexisting hypomagnesemia, which induces hypoparathyroidism as well as resistance to parathyroid hormone (PTH). Here, we present two patients with severe hypomagnesemia and associated hypocalcemia, caused by proton ...
Naqvi, Ali
core   +1 more source

Home - About - Disclaimer - Privacy